Embryonic and induced pluripotent stem cells as a model for liver disease

Hiroshi Yagi, Edgar Tafaleng, Masaki Nagaya, Marc C. Hansel, Stephen C. Strom, Ira J. Fox, Alejandro Soto-Gutierrez

研究成果: Review article査読

8 被引用数 (Scopus)

抄録

Induced pluripotent stem (iPS) cells are human somatic cells that have been reprogrammed to a pluripotent state. Through several elegant technologies, we are now able to generate human iPS cells with disease genotypes that could serve as invaluable tools for human disease modeling. This could lead to an understanding of the root causes of a disease and to the development of effective prophylactic and therapeutic strategies for it. However, we are still far from generating fully functional liver cells from stem cells, including iPS cells, on in vitro culture systems. Tissue-engineering techniques have opened the window to inducing a functional fate for differentiated cells by providing a microenvironment that allows the maintenance of signals similar to those found in the natural microenvironment. Here we review the current technology to establish iPS cells and discuss strategies to generate human liver disease modeling using iPS cell technology in concert with bioengineering approaches.

本文言語English
ページ(範囲)377-398
ページ数22
ジャーナルCritical Reviews in Biomedical Engineering
37
4-5
DOI
出版ステータスPublished - 2009

ASJC Scopus subject areas

  • Biomedical Engineering

フィンガープリント 「Embryonic and induced pluripotent stem cells as a model for liver disease」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル